Login

4D Pharma finds success for its Parkinson’s treatment - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D Pharma (DDDD) to move its treatment for Parkinson’s disease into trials

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
AMC CEO Adam Aron on Reopening New York City Theaters and the Impact of Retail Trading Frenzy | Adam Aron, CEO, AMC Entertainment Holdings Inc.
00:10:00
Zigg Capital: Pioneering the Future of Real Estate and Technology Investments with a $335 Million Vision|Dave Eisenberg Founding Partner at Zigg Capital
00:10:00
The Group 2CRSi. An inspiring tale from our founder and CEO, Alain Wilmouth | Alain Wilmouth, CEO, 2Crsi SAAL2SI:PAR
00:00:00
Shield Therapeutics talks extension of cash runway following US$10 million financing - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:10:00
Canaan is a long time early-stage investor|Deepak Kamra,General Partner,Canaan Partners
00:10:00
Blackrock Graphite: From Scoping Study to Bankable Feasibility in Tanzania
00:10:00
"Crafting Authentic Advisor Websites: Insights from Catina Koenig of The Koenig Jones Group | Catina Koenig - Co-Founder, The Koenig Jones Group"
00:10:00
During a post-NRF 2022 panel, VTEX Co-CEO and cofounder Mariano Gomide de Faria discusses entrepreneurship with David Schonthal.|Gomide de Faria is our Founder and Co-Chief Executive Officer,
00:10:00
We are one of the world’s leading fund platforms, focused on delivering truly differentiated alternative investment strategies for our clients | Paul Holmes,Global Head of Distribution,Lumyna - American Debt - Government UCITS Fund
00:00:00
Dr. Kunwar Shailubhai, CEO, Tiziana Life Sciences
00:10:00
Designing 91 Squarefeet of startup success|Amit Bansal,Partner,Digitalis Ventures
00:10:00
Insights from an Executive on Renewable Energy, Market Dynamics, and Social Responsibility in Today's Economic Climate | João Manso Neto, CEO, Greenvolt Energias Renovaveis SA.

© 2026 Nehu